Reply from the General Accounting Office

Dear Colleagues,

Following SFEE’s letter (30/6) entitled: Pharmaceutical products exclusion from capital controls, please find below the reply we have just received from the General Accounting Office (GAO).

—–Original Message—–

From: [email protected] [mailto:[email protected]] Sent: Friday, July 03, 2015 10:54 AM


Cc: [email protected]; [email protected]

Subject: Reply from the General Accounting Office

Good morning.

Following your request as of 30/06/2015 to the Committee Bank of Transactions, on the exclusion of pharmaceutical products from the capital controls, we would like to inform you that your requests must be submitted through the Bank with which you work .

So far the Committee of Bank Transactions has already approved several requests from Banks on behalf of their clients, concerning payments abroad to import medicines.

With respect,

Approval Committee Banking